| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1004091931 |
| P356 | DOI | 10.1038/NRC1295 |
| P3181 | OpenCitations bibliographic resource ID | 3182959 |
| P698 | PubMed publication ID | 14993901 |
| P5875 | ResearchGate publication ID | 5942601 |
| P50 | author | Martin A. Nowak | Q87451 |
| Yoh Iwasa | Q8054430 | ||
| Franziska Michor | Q33177805 | ||
| P2860 | cites work | Two genetic hits (more or less) to cancer | Q22251289 |
| The role of chromosomal instability in tumor initiation | Q24541508 | ||
| A new theory on cancer-inducing mechanism | Q24564810 | ||
| The age distribution of cancer and a multi-stage theory of carcinogenesis | Q24564904 | ||
| Mutation and cancer: statistical study of retinoblastoma | Q24618185 | ||
| Genetic instabilities in human cancers | Q28131826 | ||
| Local regulation of homeostasis favors chromosomal instability | Q28188687 | ||
| Putting tumours in context | Q28207789 | ||
| Cancer-susceptibility genes. Gatekeepers and caretakers | Q28236512 | ||
| ARTIFICIAL TRANSMUTATION OF THE GENE | Q28246076 | ||
| Mutation selection and the natural history of cancer | Q29614279 | ||
| DNA replication fidelity | Q29616841 | ||
| A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma | Q29618817 | ||
| A stochastic carcinogenesis model incorporating genomic instability fitted to colon cancer data. | Q30788555 | ||
| Stem cells: the intestinal stem cell as a paradigm. | Q33846215 | ||
| Investigating stem cells in human colon by using methylation patterns | Q33943888 | ||
| Somatic stem cells and the kinetics of mutagenesis and carcinogenesis | Q34075155 | ||
| Connecting chromosomes, crisis, and cancer | Q34141381 | ||
| Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression | Q34168735 | ||
| Mutation and cancer: a model for human carcinogenesis | Q34273649 | ||
| Modeling chromosomal instability and epithelial carcinogenesis in the telomerase-deficient mouse | Q34283802 | ||
| Evolutionary dynamics of biological games | Q34295025 | ||
| Multistage carcinogenesis and the incidence of colorectal cancer | Q34381339 | ||
| The linear process of somatic evolution. | Q34388658 | ||
| The mutation rate and cancer | Q34410886 | ||
| Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC. | Q34430311 | ||
| Maintenance of genome stability in Saccharomyces cerevisiae | Q34762852 | ||
| Segregating sister genomes: the molecular biology of chromosome separation | Q34762863 | ||
| Carcinogen-specific induction of genetic instability. | Q35895420 | ||
| A two-stage theory of carcinogenesis in relation to the age distribution of human cancer | Q36132593 | ||
| Analysis of the human APC mutation spectrum in a saccharomyces cerevisiae strain with a mismatch repair defect | Q38359458 | ||
| Inactivation of hCDC4 can cause chromosomal instability | Q40582502 | ||
| The tumor suppressor genes | Q40856821 | ||
| Requirement of the spindle checkpoint for proper chromosome segregation in budding yeast meiosis | Q41747330 | ||
| How many mutations in a cancer? | Q41834410 | ||
| Stochastic tunnels in evolutionary dynamics | Q42426795 | ||
| Cell biology: Developmental predisposition to cancer | Q46742483 | ||
| Genomic instability--the engine of tumorigenesis? | Q47651868 | ||
| Mutation-selection networks of cancer initiation: tumor suppressor genes and chromosomal instability. | Q52012209 | ||
| Mathematical oncology: cancer summed up. | Q52024113 | ||
| Somatic selection for and against cancer. | Q52098097 | ||
| The different effects of apoptosis and DNA repair on tumorigenesis. | Q52123831 | ||
| Continuous and discrete mathematical models of tumor-induced angiogenesis. | Q52236194 | ||
| Stochastic elimination of cancer cells. | Q53374855 | ||
| The significance of unstable chromosomes in colorectal cancer. | Q53376250 | ||
| Multiple-mutation theory of carcinogenesis. | Q53615521 | ||
| Dynamics of genetic instability in sporadic and familial colorectal cancer. | Q54528454 | ||
| Role of mutator alleles in adaptive evolution. | Q54564129 | ||
| Lineage selection and the evolution of multistage carcinogenesis. | Q55032938 | ||
| In vivo human somatic mutation: frequency and spectrum with age | Q67534625 | ||
| Tumor suppressor genes | Q68264184 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 197-205 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | Nature Reviews Cancer | Q641657 |
| P1476 | title | Dynamics of cancer progression | |
| P478 | volume | 4 |
| Q36429393 | 3p21.3 tumor suppressor cluster: prospects for translational applications |
| Q36074227 | A Big Bang model of human colorectal tumor growth |
| Q43122680 | A cheater lineage in a social insect: Implications for the evolution of cooperation in the wild |
| Q92453130 | A compartment size-dependent selective threshold limits mutation accumulation in hierarchical tissues |
| Q33576721 | A differentiation-based phylogeny of cancer subtypes |
| Q64081122 | A generalized theory of age-dependent carcinogenesis |
| Q34128350 | A mathematical-biological joint effort to investigate the tumor-initiating ability of Cancer Stem Cells |
| Q37812550 | A passage through systems biology to systems medicine: adoption of middle-out rational approaches towards the understanding of therapeutic outcomes in cancer |
| Q37377284 | A progenitor cell origin of myeloid malignancies |
| Q41934744 | A statistical model for the identification of genes governing the incidence of cancer with age. |
| Q38758032 | Advances in understanding tumour evolution through single-cell sequencing |
| Q39133502 | Advancing cancer patient care by integrating circulating tumor cell technology to understand the spatial and temporal dynamics of cancer |
| Q37119366 | An evolutionary hybrid cellular automaton model of solid tumour growth |
| Q36822207 | Bevacizumab for glioblastoma: current indications, surgical implications, and future directions |
| Q92596939 | Biological Significance of Tumor Heterogeneity in Esophageal Squamous Cell Carcinoma |
| Q36340108 | Biomarkers and the genetics of early neoplastic lesions |
| Q24816263 | Bystander effects in UV-induced genomic instability: antioxidants inhibit delayed mutagenesis induced by ultraviolet A and B radiation |
| Q43217796 | Cancer Molecular Evolution |
| Q22122026 | Cancer as an evolutionary and ecological process |
| Q27002537 | Cancer evolution: mathematical models and computational inference |
| Q27690285 | Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution. |
| Q44032656 | Cancer heterogeneity and drug metabolism: what we know and what we need to know |
| Q42411337 | Cancer heterogeneity: origins and implications for genetic association studies |
| Q38548568 | Cancer quasispecies and stem-like adaptive aneuploidy |
| Q35960758 | Cancer research meets evolutionary biology. |
| Q25257555 | Cancer: looking for simplicity and finding complexity |
| Q51038972 | Catastrophic shifts and lethal thresholds in a propagating front model of unstable tumor progression. |
| Q34893246 | Cell selection as driving force in lung and colon carcinogenesis |
| Q46260077 | Chemotherapeutic Dose Scheduling Based on Tumor Growth Rates Provides a Case for Low-Dose Metronomic High-Entropy Therapies. |
| Q42258874 | Chromosomal instability and human cancer |
| Q37566249 | Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues. |
| Q37028962 | Clonal diversity in carcinomas: its implications for tumour progression and the contribution made to it by epithelial-mesenchymal transitions |
| Q22252319 | Clonal origin and evolution of a transmissible cancer |
| Q55191112 | Comparison of Clinical Subgroup aCGH Profiles through Pseudolikelihood Ratio Tests. |
| Q26769024 | Computational Cancer Biology: An Evolutionary Perspective |
| Q42712922 | Conditional coalescent trees with two mutation rates and their application to genomic instability. |
| Q91721196 | Correlation Analysis of Histopathology and Proteogenomics Data for Breast Cancer |
| Q41888157 | Correlation between oncogenic mutations and parameter sensitivity of the apoptosis pathway model |
| Q51553614 | DNA replication timing and selection shape the landscape of nucleotide variation in cancer genomes. |
| Q79777489 | Darwinian medicine: a case for cancer |
| Q40322633 | Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis |
| Q36149716 | Defining order and timing of mutations during cancer progression: the TO-DAG probabilistic graphical model |
| Q36563003 | Diversity of Gene Expression in Hepatocellular Carcinoma Cells |
| Q36670951 | Dynamics of biological systems: role of systems biology in medical research |
| Q34287334 | Effect of chromosomal instability on the mutation-selection balance in unicellular populations |
| Q47663441 | Effect of migration in a diffusion model for template coexistence in protocells |
| Q89599719 | Eleven grand challenges in single-cell data science |
| Q91933407 | Elucidating the correlations between cancer initiation times and lifetime cancer risks |
| Q101574097 | Enhanced risk of cancer in companion animals as a response to the longevity |
| Q58734090 | Environmental Carcinogenesis and Transgenerational Transmission of Carcinogenic Risk: From Genetics to Epigenetics |
| Q46479120 | Estimating rare events in biochemical systems using conditional sampling. |
| Q39296522 | Evolution of Premalignant Disease. |
| Q27020991 | Evolution of the cancer genome |
| Q38679257 | Evolutionary Origins of Cancer Driver Genes and Implications for Cancer Prognosis. |
| Q51727179 | Evolutionary biology of cancer. |
| Q26801710 | Evolutionary determinants of cancer |
| Q42067716 | Evolutionary dynamics of chronic myeloid leukemia |
| Q42451818 | Evolutionary dynamics of tumor progression with random fitness values |
| Q36986424 | Evolutionary dynamics of tumor suppressor gene inactivation. |
| Q42323232 | Evolutionary shift dynamics on a cycle |
| Q36725770 | Examples of mathematical modeling: tales from the crypt |
| Q30820685 | Excess of mutational jackpot events in expanding populations revealed by spatial Luria-Delbrück experiments |
| Q22122016 | Functional mapping — how to map and study the genetic architecture of dynamic complex traits |
| Q37301932 | Genetic changes of non-small cell lung cancer under neoadjuvant therapy |
| Q41518553 | Genetic instability and clonal expansion |
| Q21563505 | Genetic progression and the waiting time to cancer |
| Q35891370 | Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneity |
| Q33836026 | Genomic and epigenetic instability in colorectal cancer pathogenesis |
| Q40998566 | Genotype by random environmental interactions gives an advantage to non-favored minor alleles. |
| Q60959882 | High MYC Levels Favour Multifocal Carcinogenesis |
| Q38484630 | High resolution integrative analysis reveals widespread genetic and epigenetic changes after chronic in-vitro acid and bile exposure in Barrett's epithelium cells |
| Q38910371 | Homeostasis Back and Forth: An Ecoevolutionary Perspective of Cancer |
| Q33522193 | Identification of networks of co-occurring, tumor-related DNA copy number changes using a genome-wide scoring approach |
| Q47771251 | Inferring the paths of somatic evolution in cancer |
| Q38769921 | Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals |
| Q31039903 | Integrating mutation and gene expression cross-sectional data to infer cancer progression |
| Q33440553 | MYC prevents apoptosis and enhances endoreduplication induced by paclitaxel |
| Q35226909 | Maintenance Therapy Containing Metformin and/or Zyflamend for Advanced Prostate Cancer: A Case Series |
| Q51339205 | Mathematical modeling of therapeutic strategies for myeloid malignancies. |
| Q33259239 | Mathematical modeling of tumor therapy with oncolytic viruses: effects of parametric heterogeneity on cell dynamics |
| Q25257260 | Mathematical modeling of tumor therapy with oncolytic viruses: regimes with complete tumor elimination within the framework of deterministic models |
| Q41576528 | Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development |
| Q90425693 | Mathematical modelling the pathway of genomic instability in lung cancer |
| Q36619319 | Mathematical models of targeted cancer therapy |
| Q35162521 | Mechanisms governing metastatic dormancy and reactivation |
| Q38673360 | Mechanistic mathematical models: An underused platform for HPV research |
| Q37615286 | Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking? |
| Q33590430 | Modeling Tumor Clonal Evolution for Drug Combinations Design |
| Q51010979 | Modeling age-dependent radiation-induced second cancer risks and estimation of mutation rate: an evolutionary approach. |
| Q92180451 | Modeling breast cancer progression to bone: how driver mutation order and metabolism matter |
| Q45371379 | Modeling of stem cell dynamics in human colonic crypts in silico. |
| Q44537059 | Moderate stem-cell telomere shortening rate postpones cancer onset in a stochastic model. |
| Q26801921 | Molecular and genetic aspects of odontogenic tumors: a review |
| Q39064808 | Monoclonal antibody preparation and expression profile analysis of a novel hepatoma associated gene |
| Q53490850 | Multiple mutant clones in blood rarely coexist. |
| Q38799677 | Multistage carcinogenesis |
| Q40274213 | Nuclear-mitochondrial genomic profiling reveals a pattern of evolution in epithelial ovarian tumor stem cells. |
| Q49980891 | Optimizing homeostatic cell renewal in hierarchical tissues. |
| Q33293460 | Paradoxes in carcinogenesis: new opportunities for research directions |
| Q36895345 | Pathogenesis, treatment effects, and resistance dynamics in chronic myeloid leukemia--insights from mathematical model analyses |
| Q61449569 | Patterns of Tumor Progression Predict Small and Tissue-Specific Tumor-Originating Niches |
| Q94406837 | Personalised cancer care: promises and challenges of targeted therapy |
| Q64116423 | Phylostratigraphic analysis of gene co-expression network reveals the evolution of functional modules for ovarian cancer |
| Q21245316 | Phylostratigraphic tracking of cancer genes suggests a link to the emergence of multicellularity in metazoa |
| Q37746085 | Physico-mechanical aspects of extracellular matrix influences on tumorigenic behaviors |
| Q30859909 | Plausibility of stromal initiation of epithelial cancers without a mutation in the epithelium: a computer simulation of morphostats |
| Q36500617 | Positive selection in the evolution of cancer |
| Q52590824 | Protective Effect of Allyl Isothiocyanate on Glycoprotein Components in 7,12-dimethylbenz(a)anthracene Induced Mammary Carcinoma in Rats. |
| Q33847536 | Quantitative interpretation of a genetic model of carcinogenesis using computer simulations |
| Q53641003 | Rapid and convergent evolution in the glioblastoma multiforme genome. |
| Q51097608 | Runx3 and Cell Fate Decisions in Pancreas Cancer. |
| Q37128946 | Somatic mutation signatures of cancer. |
| Q28544732 | Spatial heterogeneity in drug concentrations can facilitate the emergence of resistance to cancer therapy |
| Q42202619 | Spatial structure increases the waiting time for cancer. |
| Q35789091 | Stem cell niche dynamics: from homeostasis to carcinogenesis. |
| Q36800416 | Stochastic Hypothesis of Transition from Inborn Neutropenia to AML: Interactions of Cell Population Dynamics and Population Genetics |
| Q43235502 | Stochastic dynamics of cancer initiation |
| Q35342578 | Stochastic tunneling and metastable states during the somatic evolution of cancer. |
| Q96128914 | Supramolecular Polysaccharide Nanotheranostics that Inhibit Cancer Cells Growth and Monitor Targeted Therapy Response |
| Q64978569 | TIP60 represses activation of endogenous retroviral elements. |
| Q35075559 | The age incidence of chronic myeloid leukemia can be explained by a one-mutation model |
| Q35946514 | The dynamics of drug resistance: a mathematical perspective |
| Q42986683 | The evolution of two mutations during clonal expansion |
| Q38454299 | The fastest evolutionary trajectory |
| Q41872274 | The pace of evolution across fitness valleys |
| Q46495434 | The prisoner's dilemma as a cancer model. |
| Q34070603 | The temporal order of genetic and pathway alterations in tumorigenesis |
| Q92908508 | Three-dimensional tumor growth in time-varying chemical fields: a modeling framework and theoretical study |
| Q52617828 | Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium. |
| Q37386249 | Translational genomics in cancer research: converting profiles into personalized cancer medicine |
| Q41474606 | Tumor and the microenvironment: a chance to reframe the paradigm of carcinogenesis? |
| Q33624298 | Tumor heterogeneity: causes and consequences |
| Q35795835 | Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design |
| Q35055173 | Tumor-specific chromosome mis-segregation controls cancer plasticity by maintaining tumor heterogeneity |
| Q51139804 | Tumors as chaotic attractors. |
| Q34208808 | What does physics have to do with cancer? |
| Q89082200 | β-catenin/TCF activity regulates IGF-1R tyrosine kinase inhibitor sensitivity in colon cancer |
Search more.